Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

184.86
Delayed Data
As of Apr 28
 +1.12 / +0.61%
Today’s Change
119.37
Today|||52-Week Range
186.88
+44.38%
Year-to-Date

Today’s Trading

Previous close183.74
Today’s open184.62
Day’s range182.95 - 185.95
Volume1,083,986
Average volume (3 months)1,106,945
Market cap$27.0B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.23%
Earnings growth (next 5 years)+13.15%
Revenue growth (last year)+8.05%
P/E ratio60.2
Price/Sales7.90
Price/Book12.30

Competitors

 Today’s
change
Today’s
% change
BIVVBioverativ Inc+0.72+1.24%
NBIXNeurocrine Bioscienc...-0.19-0.35%
KITEKite Pharma Inc-0.56-0.68%
TECHBio-Techne Corp+0.46+0.43%
Data as of 4:14pm ET, 04/28/2017

Financials

Last reporting dateApril 25, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Chief Financial Officer &
Senior Vice President
Sam A. Samad
Corporate headquarters
San Diego, California

Forecasts